MDEV vs. ARKG
Compare and contrast key facts about First Trust Indxx Medical Devices ETF (MDEV) and ARK Genomic Revolution Multi-Sector ETF (ARKG).
MDEV and ARKG are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. MDEV is a passively managed fund by First Trust that tracks the performance of the Indxx Global Medical Equipment Index. It was launched on Jun 22, 2021. ARKG is an actively managed fund by ARK Investment Management. It was launched on Oct 31, 2014.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MDEV or ARKG.
Key characteristics
| MDEV | ARKG | |
|---|---|---|
| YTD Return | 6.87% | -21.08% |
| 1Y Return | 27.20% | 7.99% |
| 3Y Return (Ann) | -6.78% | -30.28% |
| Sharpe Ratio | 1.77 | 0.08 |
| Sortino Ratio | 2.60 | 0.43 |
| Omega Ratio | 1.31 | 1.05 |
| Calmar Ratio | 0.64 | 0.04 |
| Martin Ratio | 6.87 | 0.15 |
| Ulcer Index | 3.67% | 21.95% |
| Daily Std Dev | 14.23% | 40.68% |
| Max Drawdown | -42.34% | -80.10% |
| Current Drawdown | -22.97% | -76.83% |
Correlation
The correlation between MDEV and ARKG is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
MDEV vs. ARKG - Performance Comparison
In the year-to-date period, MDEV achieves a 6.87% return, which is significantly higher than ARKG's -21.08% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
MDEV vs. ARKG - Expense Ratio Comparison
MDEV has a 0.70% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Risk-Adjusted Performance
MDEV vs. ARKG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Indxx Medical Devices ETF (MDEV) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MDEV vs. ARKG - Dividend Comparison
Neither MDEV nor ARKG has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
MDEV First Trust Indxx Medical Devices ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 1.94% | 1.34% |
Drawdowns
MDEV vs. ARKG - Drawdown Comparison
The maximum MDEV drawdown since its inception was -42.34%, smaller than the maximum ARKG drawdown of -80.10%. Use the drawdown chart below to compare losses from any high point for MDEV and ARKG. For additional features, visit the drawdowns tool.
Volatility
MDEV vs. ARKG - Volatility Comparison
The current volatility for First Trust Indxx Medical Devices ETF (MDEV) is 3.51%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 9.92%. This indicates that MDEV experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.